ArticleEcancermedicalscience2022
Eye metastasis in breast cancer: case report and review of literature.
Article in Ecancermedicalscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 15 citations in OpenAlex.
- Prediction model for ocular metastasis of breast cancer: machine learning model development and interpretation study.BMC cancer · 2024Article
- General characteristics of orbital metastasis in breast cancer: a narrative review of case reports.International cancer conference journal · 2024Review
- Symptomatic orbital metastasis as an initial presentation of adenocarcinoma lung: A case report and review of literature.Lung India : official organ of Indian Chest Society · 2024Article
- From Breast to Orbit: A Case Report of Metastatic Breast Cancer With Orbital Involvement.Cureus · 2024Article
- Uncommon orbital metastasis in ductal breast carcinoma: a rare presentation 12 years after treatment.Journal of surgical case reports · 2024Article
- Optic Nerve Metastasis in Lung Adenocarcinoma.Cureus · 2024Article
- Orbital Metastasis from Breast Cancer: Three Cases and Brief Review of the Literature.Beyoglu eye journal · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The paradigm of breast cancer management has been revolutionised, resulting in prolonged survival that echoes an increasing incidence of metastasis in uncommon sites. With orbital metastases - despite being rare - the incidence scales up to 13% of breast cancer cases with no specific management guidelines. We report a case of a 31-year-old luminal B breast cancer patient who initially presented with T2N2M0 disease and received six cycles of adjuvant chemotherapy (5-Fluorouracil (5-FU) 600 mg/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.